| Roivant Sciences Ltd.(ROIV) | SHS | G76279101 | $125.9M | 12,480,000 | 52.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $25.2M | 330,250 | 10.4% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $22.5M | 1,522,452 | 9.3% |
| Eyepoint Pharmaceuticals, Inc.(EYPT) | COM NEW | 30233G209 | $8.0M | 1,481,977 | 3.3% |
| Ocular Therapeutix, Inc.(OCUL) | COM | 67576A100 | $6.7M | 920,199 | 2.8% |
| Cullinan Therapeutics, Inc.(CGEM) | COM | 230031106 | $6.7M | 878,897 | 2.8% |
| Nurix Therapeutics, Inc.(NRIX) | COM | 67080M103 | $5.3M | 447,296 | 2.2% |
| Mirum Pharmaceuticals, Inc.(MIRM) | COM | 604749101 | $5.2M | 116,362 | 2.2% |
| Enliven Therapeutics, Inc.(ELVN) | COM | 29337E102 | $5.0M | 253,838 | 2.1% |
| Scholar Rock Holding Corporation(SRRK) | COM | 80706P103 | $5.0M | 154,000 | 2.0% |
| Disc Medicine, Inc.(IRON) | COM | 254604101 | $4.1M | 83,000 | 1.7% |
| Agios Pharmaceuticals, Inc.(AGIO) | COM | 00847X104 | $4.1M | 139,732 | 1.7% |
| Kymera Therapeutics, Inc.(KYMR) | COM | 501575104 | $3.9M | 142,201 | 1.6% |
| Pharvaris N. V.(PHVS) | COM | N69605108 | $3.9M | 245,496 | 1.6% |
| Allogene Therapeutics, Inc.(ALLO) | COM | 019770106 | $3.5M | 2,368,186 | 1.4% |
| Blueprint Medicines Corporation(2L9) | COM | 09627Y109 | $3.4M | 38,500 | 1.4% |
| Intellia Therapeutics, Inc.(NTLA) | COM | 45826J105 | $1.7M | 232,781 | 0.7% |
| Soleno Therapeutics, Inc.(SLNO) | COM | 834203309 | $1.3M | 18,600 | 0.5% |
| Vyne Therapeutics Inc.(VYNE) | COM | 92941V308 | $406.1K | 257,033 | 0.2% |